Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMS-101 in burn patients
NCT06440239Phase 2Not yet recruiting
- Sponsor
- Primoris Therapeutics Co., Ltd.
- Start
- Jan 2025
- Primary completion
- Feb 2025
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of PMS-101 in burn injury, sponsored by Primoris Therapeutics Co., Ltd.. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
PMS-101
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT06440239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440239.